| dc.creator | Speisky Cosoy, Hernán | |
| dc.creator | Cassels Niven, Bruce | |
| dc.creator | Lissi Gervaso, Eduardo A. | |
| dc.creator | Videla Cabrera, Luis | |
| dc.date.accessioned | 2019-01-29T14:49:31Z | |
| dc.date.available | 2019-01-29T14:49:31Z | |
| dc.date.created | 2019-01-29T14:49:31Z | |
| dc.date.issued | 1991 | |
| dc.identifier | Biochemical Pharmacology, Volumen 41, Issue 11, 2018, Pages 1575-1581 | |
| dc.identifier | 00062952 | |
| dc.identifier | 10.1016/0006-2952(91)90156-Y | |
| dc.identifier | http://repositorio.uchile.cl/handle/2250/160896 | |
| dc.description.abstract | Boldine, in low micromolar concentrations, was able to prevent brain homogenate autooxidation, the 2,2'-azobis(2-amidinopropane)(AAP)-induced lipid peroxidation of red cell plasma membranes, and the AAP-induced inactivation of lysozyme. These results are indicative of a high reactivity of boldine towards free radicals. The analysis of the boldine effect as a function of incubation times suggests that a metabolite resulting from the interaction of boldine with free radicals also exhibits antioxidant activity, being more efficient than boldine in brain homogenate auto-oxidation and less efficient in lysozyme protection experiments. This behavior may be accounted for in terms of the relative location of the scavengers needed to afford maximal protection. © 1991. | |
| dc.language | en | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
| dc.source | Biochemical Pharmacology | |
| dc.subject | Biochemistry | |
| dc.subject | Pharmacology | |
| dc.title | Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation | |
| dc.type | Artículos de revistas | |